Short Interest in Nutriband Inc. (NASDAQ:NTRBW) Grows By 9,600.0%

Nutriband Inc. (NASDAQ:NTRBW) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,746 shares, an increase of 9,600.0% from the August 15th total of 18 shares. Based on an average daily trading volume, of 10,970 shares, the short-interest ratio is currently 0.2 days.

Nutriband Stock Up 54.2%

NASDAQ:NTRBW opened at $0.60 on Friday. Nutriband has a 52-week low of $0.17 and a 52-week high of $2.99. The stock’s 50-day simple moving average is $0.54 and its 200 day simple moving average is $0.97.

Institutional Investors Weigh In On Nutriband

An institutional investor recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new stake in Nutriband Inc. (NASDAQ:NTRBW) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises about 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th biggest holding.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.